Date: June 29, 2021
Time: 7:00am (PDT), 10:00am (EDT)
The Unyvero Lower Respiratory Tract Panel demonstrated reliable concordance with culture based methods for organism identification from bronchoalveolar lavage samples, including relevant resistance mechanisms. Clinically, the Unyvero Lower Respiratory Tract Panel aided in both rapid escalation and de-escalation of antimicrobial therapy in our evaluation. Results generated from Unyvero in this single center evaluation allowed for more rapid adjustments in antimicrobial therapy in 53% of cases. Rapid de-escalation of toxic agents such as vancomycin may help prevent negative complications in critically ill patients.
- Discuss the principle of operation of the Unyvero Lower Respiratory Tract Panel and the detection of the most common etiological agents associated with hospital-acquired and ventilator-associated pneumonia, and detection of critical resistance markers for Gram- positive and Gram-negative microorganisms
- Outline the clinical impact of real time actionable, rapid results on antimicrobial stewardship and patient management.
- Demonstrate the analytical performance of the multiplex Pneumonia Panel compared to conventional culture and antimicrobial susceptibility results.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.